Roche completes $4.3B purchase of Philadelphia gene therapy pioneer Spark Therapeutics

Roche completes its $4.3 billion purchase of our region’s own Spark Therapeutics in a historic acquisition. This is a milestone achievement for Greater Philadelphia as an epicenter of talent, research and results in gene therapy.

Article from the Philadelphia Business Journal